SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001193125-15-071643
Filing Date
2015-03-02
Accepted
2015-03-02 07:02:34
Documents
4

Document Format Files

Seq Description Document Type Size
1 POS AM d882336dposam.htm POS AM 281954
2 EX-12.1 d882336dex121.htm EX-12.1 25196
3 EX-23.1 d882336dex231.htm EX-23.1 2380
4 GRAPHIC g882336new.jpg GRAPHIC 2514
  Complete submission text file 0001193125-15-071643.txt   314408
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-184807 | Film No.: 15662266
SIC: 2834 Pharmaceutical Preparations